Qualyst, Inc. Licenses B-CLEAR(R), A Proprietary Pharmacokinetic Product From Covance Laboratories Inc.

RALEIGH, N.C., U.S.A. (Oct 18, 2006) Qualyst today announced that Covance Laboratories, Inc., one of the world's largest and most comprehensive drug development services companies, has licensed the use of Qualyst’s proprietary, patented B-CLEAR® system to provide its pharmaceutical and biotechnology sponsors with pharmacokinetic services. Terms were not disclosed.
MORE ON THIS TOPIC